Trump's FDA Nominee Makary Promises Role for Vaccine Expert Committee
Makary has promised to convene the agency's vaccine advisory committee, but does not commit to rescheduling a canceled meeting to discuss flu vaccine composition. The nomination of Martin Makary as the new FDA chief has raised concerns about his views on vaccines and reproductive rights. Makary, a physician at Johns Hopkins Hospital, would report to Health Secretary Robert F. Kennedy Jr.
- As the COVID-19 pandemic continues to evolve, it is essential to assess how vaccine expert committees like Makary's will balance scientific evidence with political pressure in shaping public health policy.
- Will the appointment of Makary as FDA chief lead to a more politicized approach to regulating medications and vaccines, potentially undermining the agency's independence?